BackAdamis Pharmaceuticals Overview

Adamis Pharmaceuticals Receivables

Latest receivables for ADMP: $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
100.00% YoYΔ $-1.55M vs prior year quarter

Peer average

Loading

Adamis Pharmaceuticals Receivables History

Loading

Adamis Pharmaceuticals vs. peers: Receivables Comparison

Loading

Adamis Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Adamis Pharmaceuticals (ADMP) FAQ

As of the most recent data (September 2023), ADMP shows a receivables of $0. That compares with $1.6M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADMP's receivables is now $0 (was $1.6M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Adamis Pharmaceuticals is outperforming or lagging.

Tracking ADMP's receivables over time shows whether Adamis Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $1.6M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Adamis Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.

Adamis Pharmaceuticals's receivables is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.